Introduction
devastating abnormalities in early childhood 3 and might Alteration of gene expression has provided a fundamencircumvent limitations seen in the adult animal. In fact, tal paradigm for assessment of gene function in both norseveral studies have documented prolonged expression mal and pathological processes and the ability to introwhen adenoviral viral vectors are administered in the duce functional DNA into somatic cells has prompted the neonatal period. [4] [5] [6] Most recently, studies have focused initial development of numerous strategies for the correcon the utility of adenovirus-mediated gene transduction tion or replacement of defective genes in affected individfor in utero gene therapy during the latter stages of preuals. To this end, much attention has been paid to the natal development 7-10 and adenoviral vectors have even development of vectors that can serve to carry genes into been used as a method of gene transfer into embryonic cells without themselves affecting normal cellular funcstem cells. 11 However, there is limited information contion. One of the most prominent vectors in use at the cerning the effect of these vectors on fetal development present time is the replication-deficient adenovirus. 1, 2 or on the pattern of gene expression in the developing This vector has many advantages: the virus has a broad embryo and there is no information on adenovirushost range including both replicating and quiescent cells mediated gene expression during the initial period of and can therefore transduce many different cells, the organogenesis in the mammal which is a critical period efficiency of exogenous gene delivery and subsequent for normal development and particularly important for expression can be extremely high, it does not normally morphogenesis of the cardiovascular system. integrate into the host genome, and it has minimal effect In order to evaluate the feasibility of using replicationon intrinsic host cell function. Unfortunately, a major deficient adenovirus for in utero gene delivery during the limitation in the use of this vector for gene therapy has initial stages of organogenesis in the mammal, we have been the development of an immune response to residual injected an adenovirus vector carrying the bacterial ␤-viral proteins and/or encoded foreign protein that has galactosidase gene (lacZ) under the control of either the resulted in attenuated transgene expression in the cytomegalovirus (CMV) promoter or the Rous sarcoma mature animal.
virus (RSV) long terminal repeat (LTR) into cultured, In principle, the introduction of normal genes or post-implantation mouse embryos. The distribution of cDNAs encoding appropriate genetic products in utero or cells expressing the lacZ reporter was evaluated 24 to 48 h in the early postnatal period could be one of the most later. The results show that this vector can be used quite effectively to deliver genes to the early embryo without detectable effects on initial morphogenesis. In addition, injected into the pericardial (pc) space of an embryonic
Results
day (E) 7.75 mouse embryo exposing the entire head region including the neural fold (nf) and precardiac Gene expression controlled by the CMV promoter is mesoderm to virus. Embryos at this stage are approxirestricted to the endothelium mately equivalent in development to 17-day human A replication-deficient adenovirus vector carrying the embryos. The injected embryos were cultured for an gene for bacterial ␤-galactosidase (lacZ) under the control additional 36 h, fixed and evaluated for ␤-galactosidase of the cytomegalovirus (CMV) enhancer and promoter (␤-gal) as described below (Figure 1b, c and d) . At the was used to evaluate gene expression at the cellular level time of fixation, development of the head, eye, heart and in early, post-implantation mouse embryos. Initially, limb buds had progressed appropriately, and the beating embryos were injected with approximately 10 to 100 picoheart was in the process of dividing into a four chambliters of virus stock containing 0.5 to 1 × 10 12 particles per ered, functional organ with endocardial cushion formamilliliter. Phenol red was added to allow the visualiztion already initiated. There was no difference in embryo ation of the injected viral solution. Figure 1a shows the route of vector administration. In this case, vector was size or morphology between embryos injected with virus Figure 1b and saline-injected controls and ␤-gal expression was restricted to the developing vasculature and endocardium c shows that the extent of lacZ expression reflected the amount of vector administered. Surprisingly, however, ␤- (Figure 3b) . Examination of the heart in the region of atrioventricular cushion (avc) formation showed that the gal activity was detected only in cells aligned in a pattern resembling that of the developing endocardium and vasendocardial cells invading the endocardial cushion continued to express ␤-gal following delamination and culature (Figure 1b and c) . Indeed, the expression pattern noted here resembles that of a comparable embryo migration into the cushion matrix ( Figure 3c ). Thus, delaying vector administration for 24 h did not result in stained with a monoclonal antibody specific for the endothelial cell marker PECAM-1(CD31). 12 For better localizmore extensive ␤-gal expression. In addition, once expressed, ␤-gal continued to be synthesized by endoation of lacZ-positive cells, the embryos were sectioned following X-gal staining (Figure 1d) . A sagittal section thelial cells even though they had undergone transformation to a mesenchymal, invasive phenotype suggesting through the heart of an embryo injected as in Figure 1a revealed ␤-gal synthesis only by cells forming the endothat viral infection and exogenous reporter gene expression did not interfere with the initiation of this cardium of the heart and the endothelium of developing blood vessels.
critical process.
Gene expression can be detected within 3 h of vector Susceptibility to adenovirus transfection is independent of site of injection in the early embryo administration In order to determine the approximate kinetics of gene To test the susceptibility of early embryonic cells to adenovirus infection further, E 7.25 embryos were injected in expression as well as the progression of expression during development, E 7.75 embryos were injected with the only one side of the early head process (Figure 2a ), thus exposing the neural ectoderm, head mesenchyme and vector as shown in Figure 1 and sequentially removed from culture for X-gal staining. The results in Figure 4 cranial neural crest cells as well as early endothelial cell populations to infective virus. After 36 h in culture, the show that ␤-gal expression was detected as early as 3 h following virus administration and appeared maximal embryos were harvested, stained for ␤-gal activity and examined in both whole mount ( Figure 2b ) and in sagittal between 16 and 24 h after infection. X-gal staining progressed in a pattern consistent with that of the expanding section ( Figure 2c ). Again, ␤-gal activity was detected only in endothelial cells lining major vessels, even though embryonic vasculature, and at no time was gene expression noted in regions outside that of the expanding cells composing the neural fold and head mesenchyme were also exposed to the virus (Figure 2a and b) . To vasculature. Thus, the reporter gene under the control of the CMV promoter was found to be expressed shortly determine further if gene expression was limited to endothelial cells, sagittal sections of embryos injected as in after infection, and expression was confined to the endothelial cell lineage. Figure 2a were simultaneously stained with a monoclonal antibody specific for PECAM-1 to identify endothelial cells, and a polyclonal antibody specific for bacterial ␤-Expression pattern of lacZ under the control of an RSV LTR is accentuated in the myocardium gal to detect all cells expressing the vector-mediated gene. Fluorescein isothiocyanate conjugated anti-mouse
To determine the effect of the promoter on the pattern of ␤-gal synthesis, E 7.75 embryos were injected with adenIgG was used to detect PECAM-1 expressing cells and rhodamine conjugated anti-rabbit IgG was used to identovirus carrying the lacZ gene under the control of the RSV LTR. Control embryos were injected with comparify cells expressing ␤-gal. Green immunofluorescence was noted only on cells forming the endothelium of the able amounts of the CMV-lacZ virus as described below. After 24 h in culture, embryos were harvested and pharyngeal arches (pha), dorsal aorta (da), small vessels of the head, segmental arteries and endocardium (e). stained as whole mounts for ␤-gal activity. The distribution of ␤-gal expression in the CMV lacZ control Yellow-orange fluorescence, indicating cells co-expressing ␤-gal and PECAM-1, was noted on a subpopulation embryos was similar to that noted in Figure 1c . The distribution of ␤-gal-expressing cells following RSV-lacZ of these early endothelial cells (Figure 2c and d) . No cells stained for ␤-gal were found outside the presumptive virus administration was, however, significantly different ( Figure 5b ). Blue staining was limited almost exclusively vasculature of these embryos (Figure 2d ). Thus, although the virus was administered at a time when large numbers to the developing heart (ht) and yolk sac (ys). Evaluation of cross-sections from embryos injected with RSV-driven of presumptive stem cells were arising from all three germ layers, and vasculogenesis had only initially comlacZ (Figure 5b and c) revealed marked ␤-gal expression in the myocardium (m) and pericardium (pc), but only menced, endothelial cells were the only cells expressing the lacZ marker.
weak to background expression by the endocardial cells (e) and none by cells outside the heart in the regions of the dorsal aorta (da), outflow tract (oft) or atrial ventricu-␤-Galactosidase expression persists following epithelialmesenchymal transformation of the atrioventricular lar cushion (avc). Thus, in the developing embryo, the pattern of gene expression following introduction of a endocardial cells To monitor gene expression at later stages of developreplication-deficient adenovirus vector is determined by the promoter and not by the susceptibility to vector ment, virus was injected into the sinus venosus (sv) of E 8.75 cultured embryos (Figure 3a) , and ␤-gal expression infection. was monitored after 36 h in culture. These embryos were exposed to vector 24 h later than those shown in Figures   Discussion   1 and 2 , and gene expression was monitored in cultured embryos equivalent to E 10-11 in utero (Figure 3) . Again,
The results reported here represent one of the first attempts to explore parameters that might affect virus-injected embryos were indistinguishable from utilization of adenovirus-mediated gene transduction for including those of neuronal, muscle, epithelial and mesenchymal origin in the chick embryo 16 and there are prein utero gene transfer during initial organogenesis in the mammalian embryo which is the period of fetal developvious observations of more widespread expression of genetic markers controlled by this same promoter in ment most susceptible to teratogenic perturbation. 13 In addition, we have focused attention on establishment of transgenic animals 17 and in adult or neonatal rats. 5 The differences observed in these experiments could be the cardiovascular system as this has proven to be particularly sensitive to even single gene perturbations. 14 explained by the absence of adenoviral receptors on embryonic cells at this early time of infection, the limited The restricted distribution of ␤-gal expression following intra-embryonic viral administration, particularly accessibility of certain embryonic tissues due to the route of administration, or the absence of transcription factors when under the control of the CMV promoter, was unexpected. Numerous tissues in adults and neonates have able to activate the CMV promoter in most embryonic cells. The absence of viral receptors seems unlikely as the proven susceptible to exogenous gene expression by replication-deficient adenovirus. 1, 4, 15 In addition, adenovirus secondary adenoviral receptors, the ␣v␤3 and ␣v␤5 integrins 18, 19 are expressed in a nonendothelial-specific distrigene delivery has been documented in a variety of tissues 
particles of recombinant virus containing the lacZ reporter gene via a micropipette inserted into the sinus venosus (sv). Injected solution was easily detected circulating through the heart (ht) and embryonic circulation, and was subsequently detected in the yolk sac vasculature (nf, neural folds). (b) Following culture for 36 h and removal of extraembryonic membranes, ␤-galactosidase activity could be detected throughout the vasculature of the developing embryo including the atria (a) and ventricle (v) of the developing heart, as well as the endothelium of the dorsal aorta (da), limb bud (lb), and liver primordia (lv). (c) A sagittal section through the heart of the embryo shown in b demonstrated that ␤-galactosidase activity was restricted to the endocardium (e) of the atrium, ventricle, and atrioventricular canal (avc) of the developing heart and was not detected within the myocardium (m). Of particular interest, the endothelial cells which had undergone epithelial-mesenchymal transformation and migrated into the extracellular matrix of the avc continued to express ␤-galactosidase activity (*).
bution during this period of development (data not indicated that the cellular specificity of promoter activation, not viral uptake, was indeed one of the factors shown). The route of injection, particularly when the vector was administered by intracardiac or intravenous affecting the pattern of gene expression and was somewhat surprising given previous reported experience in routes, might well limit the cells or tissues exposed to the virus. This would not appear to be the case in embryos human fetal lung where CMV and RSV appeared to be equally effective in transducing airway epithelial injected at or before E 8.5, as injection directly into the head fold failed to result in ␤-gal expression outside the cells. 22, 23 However, the strong expression of ␤-gal in the myocardium of injected embryos was consistent with the embryonic vasculature. Furthermore, the vascular endothelial cells expressing ␤-gal 24 to 36 h after injection did high expression of the chloramphenicol acetyltransferase in the heart of transgenic mice in which CAT expression not exist at the time of vector administration. They most likely were infected by residual virus upon commitment was controlled by RSV LTR 24 and has also recently been reported in the pericardium and myocardium of avian to an endothelial cell lineage. Alternatively, most cells were infected at the time of injection, but ␤-gal embryos exposed to adenoviral vectors in which transgene expression was regulated by the RSV LTR. 25 expression was activated only in those that went on to become endothelial cells. The fact that residual virus These studies suggest that the administration of an adenovirus vector to mouse embryos at a time when they could be recovered from embryos for up to 48 h after initial injection (our unpublished observations) leaves were most susceptible to external teratogens is compatible with minimal effect on the initial stages of normal open the possibility of continuous viral infection and would further suggest that accessibility to the vector was development. In the model utilized for these studies, there is over a 25-fold increase in total protein content not a limiting factor in terms of gene expression.
The pattern of lacZ expression following vector injecand total DNA of the embryo and developmental milestones are virtually identical to that seen in vivo, 26 thus it tion closely resembled that noted by Koedood et al 20 in embryos from transgenic mice carrying lacZ controlled by provides an excellent in vitro model to study early developmental events that are particularly vulnerable to perthe CMV enhancer/promoter. This is particularly striking with respect to the intense expression reported by turbation. However, it is important to point out that the embryo is developing in an environment separated from these investigators in the embryonic vasculature and endocardial cushions of their transgenic animals. These the maternal circulation thus potential maternal-fetal interactions can not be assessed. In addition, the period observations suggest that ␤-gal expression in the injected embryos might be limited to cells known to be permissive of development observed is well before the embryo has developed a competent immune system 27 which would for CMV due to the presence of transcription factors that recognize the immediate-early CMV promoter/enhancer explain the absence of an inflammatory response to the virus or transgene. Further in utero experiments are under sequences. This is consistent with recent in vitro experiments utilizing vascular smooth muscle cells where way to document the effect on later stages of development and determine if early administration of viral vector enhancer stimulation by phorbol ester administration documented that the lack of detectable gene expression results in subsequent immunotolerance. It is clear that the parameters governing successful in utero therapy will can be secondary to inefficient gene transcription despite efficient viral uptake. 21 The marked change in the pattern require careful investigations taking into account routes of administration, the changing repertoire of transcripof reporter gene expression noted here following replacement of the CMV promoter/enhancer with the RSV LTR tion factors available during embryonic differentiation, and the tissue to be targeted. While the focus of these turbations. Similarly, the ability to culture the mammalian embryo during the initial stages of organogenesis offers a investigations has been the use of viral vectors to introduce genetic material into the developing embryo, it unique opportunity to investigate critical early morphogenetic mechanisms. However, the manipulation of this should be equally possible to introduce cells following ex vivo genetic manipulations into the embryo. This latter model system has been limited by inefficient methods of effective gene transfer to the whole embryo or specific cell technique would greatly expand the number of approaches available for the correction of congenital, populations within the embryo. In this study, we document the utility of adenovirus-mediated gene transfer in developmental and biochemical defects.
Finally, these observations provide a unique paradigm combination with whole embryo culture as a method for efficient exogenous gene transduction which provides both for the study of gene expression during critical events in cardiovascular development. While the strategies of transtemporal and tissue-specific gene transduction during early organogenesis. As the heart and cardiovascular sysgenic expression and the creation of null mutations have made enormous contributions to our understanding of tem are among the earliest to form, this approach should be particularly useful in the delineation of factors regmany developmental processes, they are often limited by lack of tissue specificity or temporal regulation of gene perulating the ontogeny of these critical organ systems. 
Adenovirus injection

Materials and methods
Embryos to be injected were removed from culture and placed in 37°C PB1 media in a Petri dish on the stage Whole mouse embryo culture of a dissecting microscope (Nikon, Melville, NY, USA). Timed pregnant ICR mice were purchased from Charles Embryos were grouped according to developmental River Laboratories (Portage, MI, USA). The day of the stage, and embryos damaged during the initial dissection appearance of the vaginal plug was considered day 0. and culture were eliminated. Thawed adenovirus stocks The procedure for the culture of postimplantation mouse were diluted 1:2 with PB1 medium in order to avoid teraembryos has been well described. 26 Briefly, pregnant togenesis caused by the 3% sucrose concentration. Prefemales were killed by carbon dioxide inhalation, the liminary data in our laboratory revealed significant teraembryos harvested via Caesarean delivery, and dissected togenesis caused by injection of a 3% sucrose solution in free of the uterus in sterile 37°C PB1 medium supphysiologic PB1 medium which was greatly reduced plemented with penicillin and streptomycin. Embryos when diluted two-fold. Aluminosilicate microcapillary were dissected free of the decidua and Reichardt's mempipettes (Sutter Instruments, Novato, CA, USA) were brane, and the yolk sac was left intact. Up to five embryos pulled to a fine tapered point on a Flaming/Brown type were cultured in 5 ml of medium consisting of 70% patch horizontal micropipette puller (Sutter Instruments) immediately centrifuged rat serum and 30% sterile PB1 and broken with fine watchmakers' forceps to yield an under an atmosphere of 5% O 2 , 5% CO 2 , 90% N 2 in a angle of approximately 45°. The microcapillary injection modified hybridization oven (Robbins Scientific, Sunnypipette was then backloaded with up to 5 l of the virus vale, CA, USA) geared to 30 r.p.m. Embryos were culsolution using a microloader pipette tip (Eppendorf, tured for 2-6 h after initiation of culture before injection Madison, WI, USA). The loaded injection pipette was to allow for selection of abnormal or damaged embryos.
connected to a high-pressure microinjector (Eppendorf) and secured to a manual micromanipulator (Narishige, Preparation of high-titer adenovirus Tokyo, Japan) mounted on the stage of the dissecting Replication-deficient human type 5 adenovirus carrying microscope. This combination of instruments allowed for the E. coli lacZ gene under the control of either the cytothe injection of nanoliter volumes of the virus solution megalovirus (CMV) enhancer/promoter or the RSV LTR into many structures of the developing embryo. Estiwere generously provided by the Institute for Human mates of injection volumes were made both by calculatGene Therapy of the University of Pennsylvania. Highing the number of equal length timed injections needed titer stocks were produced by propagation in 293 cells to expel a given volume of solution and by injection of and purified as previously described. 28 Cesium chloride a solution containing radiolabeled nucleotides that could gradient-purified virus was desalted on a DG-10 column be measured on a scintillation counter. Following injec-(Bio-Rad Laboratories, Hercules, CA, USA), eluted with tion, embryos were collected and returned to the culture 3% sucrose in PBS, and stored at −70°C until injection. apparatus and gassed intermittently over a period of 24 The virus concentration was calculated by absorbance to 48 h. Embryos ranging in age from E 7.5 to E 8.75 were (OD 260 ) to be 1-2 × 10 12 particles per milliliter and the activity was further confirmed by plaque assay.
gassed with a 5% O 2 , 5% CO 2 , 90% N 2 mixture and
